The apolipoprotein E-mimetic peptide COG112 inhibits the inflammatory response to Citrobacter rodentium in colonic epithelial cells by preventing NF-kappaB activation.
about
Difluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 inductionApolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis.Apolipoprotein E-mimetics inhibit neurodegeneration and restore cognitive functions in a transgenic Drosophila model of Alzheimer's diseaseArginase II restricts host defense to Helicobacter pylori by attenuating inducible nitric oxide synthase translation in macrophagesHelicobacter pylori induces ERK-dependent formation of a phospho-c-Fos c-Jun activator protein-1 complex that causes apoptosis in macrophagesAn apolipoprotein E-mimetic stimulates axonal regeneration and remyelination after peripheral nerve injury.The apoE-mimetic peptide, COG1410, improves functional recovery in a murine model of intracerebral hemorrhage.L-arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitisEvidence that an APOE ε4 'double whammy' increases risk for Alzheimer's disease.4F decreases IRF5 expression and activation in hearts of tight skin mice.The apolipoprotein E-mimetic peptide COG112 inhibits NF-kappaB signaling, proinflammatory cytokine expression, and disease activity in murine models of colitis.Apolipoprotein E inhibits toll-like receptor (TLR)-3- and TLR-4-mediated macrophage activation through distinct mechanisms.High-throughput multi-analyte Luminex profiling implicates eotaxin-1 in ulcerative colitis.SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target.L-arginine uptake by cationic amino acid transporter 2 is essential for colonic epithelial cell restitution.Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer.Deletion of cationic amino acid transporter 2 exacerbates dextran sulfate sodium colitis and leads to an IL-17-predominant T cell responseA human apolipoprotein E mimetic peptide reduces atherosclerosis in aged apolipoprotein E null mice.ApoE deficiency promotes colon inflammation and enhances inflammatory potential oxidized-LDL and TNF-α in colon epithelial cells.Apolipoprotein E mimetics and cholesterol-lowering properties.OP449 inhibits breast cancer growth without adverse metabolic effects.EGFR-mediated macrophage activation promotes colitis-associated tumorigenesis.A new recombinant human apolipoprotein E mimetic peptide with high-density lipoprotein binding and function enhancing activity.The 5A apolipoprotein A-I (apoA-I) mimetic peptide ameliorates experimental colitis by regulating monocyte infiltration.Involvement of p38 MAPK-dependent activator protein (AP-1) activation in modulation of gastric mucosal inflammatory responses to Helicobacter pylori by ghrelin.Therapeutic Targeting of PP2A.Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury.The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis.
P2860
Q28477296-C1C67C6A-EFE0-4CD5-9F53-D302DD011D19Q30425943-62E35657-8A80-400A-B64F-AA635A9B71FDQ33517630-4CC8F89A-A9B9-47DF-B1F1-C8D575009DABQ33737915-D6ADA388-3BC2-4FAE-A037-F7CCE96FF84EQ33924459-1791A2FC-54F4-4920-B744-34FEF073992FQ34028091-B4E24128-B91A-477C-B11E-14F876144401Q34046878-36A3F278-1AEB-40EA-B9FD-5246E2F788E2Q34201063-F91BED4F-6F2A-416F-AC39-E7D8EF7BAAADQ34232205-84ADB99A-41F0-4A9D-9AEA-1080B73DABE8Q34517543-76E2FA9A-6496-4605-BE5C-59A52B37EB2EQ34537041-DE1DB876-5716-44E6-87A6-E19CB04CBC8AQ34630303-A59A5B65-6905-4D8E-BF6B-38907F8EB772Q35075300-8EDBCA49-32C2-4C03-829E-23F941AEDA1CQ35483640-F1E13889-9759-4501-B682-1BFC4EA48BA5Q35994021-B7A0F2B2-8CAB-4ECA-BC9D-64D445DFDD8DQ36050039-A079F66E-8ED7-418A-B432-8E7911ADA3B7Q37093638-C5FB45AB-0079-4EEF-88B1-77CB4D852595Q37228000-421C0A2A-67AA-4B1E-8557-294C459F776DQ37315219-52EEE186-F7F4-4E02-A099-6860E8325C77Q37965590-BDF5B246-2C3E-41D7-9D49-37864A797D8DQ38613399-25BBB284-294F-49C4-8751-836BE875176BQ38926814-10DB8591-C473-4FF9-8041-8368FBDEB060Q39442352-94B1AEF2-C4CC-4D4C-8E79-7823804D8AA4Q41341405-01A6FE8B-A14A-4695-96AD-22BF16D59C02Q43756486-94ABA27F-5591-4A51-9237-C53FCF284FFBQ47436859-B5D95736-A98D-4DEC-BBA6-DEA4481083EFQ47619892-33DB1C2A-5E05-4B71-B409-089A935EAA54Q50134122-BF3CB01D-89F1-442C-936F-BCC1703524CF
P2860
The apolipoprotein E-mimetic peptide COG112 inhibits the inflammatory response to Citrobacter rodentium in colonic epithelial cells by preventing NF-kappaB activation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The apolipoprotein E-mimetic p ...... eventing NF-kappaB activation.
@ast
The apolipoprotein E-mimetic p ...... eventing NF-kappaB activation.
@en
type
label
The apolipoprotein E-mimetic p ...... eventing NF-kappaB activation.
@ast
The apolipoprotein E-mimetic p ...... eventing NF-kappaB activation.
@en
prefLabel
The apolipoprotein E-mimetic p ...... eventing NF-kappaB activation.
@ast
The apolipoprotein E-mimetic p ...... eventing NF-kappaB activation.
@en
P2093
P2860
P356
P1476
The apolipoprotein E-mimetic p ...... eventing NF-kappaB activation.
@en
P2093
Daniel P Barry
Kshipra Singh
Michael P Vitek
Mohammad Asim
Rupesh Chaturvedi
P2860
P304
16752-16761
P356
10.1074/JBC.M710530200
P407
P577
2008-04-16T00:00:00Z